Vyome Holdings, Inc.

NASDAQ:HIND USA Biotechnology
Market Cap
$11.97 Million
Market Cap Rank
#32733 Global
#10727 in USA
Share Price
$2.12
Change (1 day)
-5.78%
52-Week Range
$1.92 - $11.51
All Time High
$11.51
About

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Vyome Holdings, Inc. (HIND) - Total Assets

Latest total assets as of September 2025: $7.05 Million USD

Based on the latest financial reports, Vyome Holdings, Inc. (HIND) holds total assets worth $7.05 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Vyome Holdings, Inc. - Total Assets Trend (2003–2024)

This chart illustrates how Vyome Holdings, Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Vyome Holdings, Inc. - Asset Composition Analysis

Current Asset Composition (December 2024)

Vyome Holdings, Inc.'s total assets of $7.05 Million consist of 95.7% current assets and 4.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 14.5%
Accounts Receivable $1.03 Million 21.5%
Inventory $2.46 Million 51.3%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how Vyome Holdings, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Vyome Holdings, Inc.'s current assets represent 95.7% of total assets in 2024, an increase from 0.0% in 2003.
  • Cash Position: Cash and equivalents constituted 14.5% of total assets in 2024, up from 0.0% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
  • Asset Diversification: The largest asset category is inventory at 51.3% of total assets.

Vyome Holdings, Inc. Competitors by Total Assets

Key competitors of Vyome Holdings, Inc. based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Vyome Holdings, Inc. - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.01 - 1.67

Strong asset utilization - Vyome Holdings, Inc. generates 1.67x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -410.24% - -38.12%

Negative ROA - Vyome Holdings, Inc. is currently not profitable relative to its asset base.

Vyome Holdings, Inc. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.94 1.33 0.57
Quick Ratio 1.94 0.60 0.43
Cash Ratio 0.00 0.00 0.00
Working Capital $2.92 Million $ 1.31 Million $ -6.12 Million

Vyome Holdings, Inc. - Advanced Valuation Insights

This section examines the relationship between Vyome Holdings, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.38
Latest Market Cap to Assets Ratio 0.68
Asset Growth Rate (YoY) -55.3%
Total Assets $4.79 Million
Market Capitalization $3.27 Million USD

Valuation Analysis

Below Book Valuation: The market values Vyome Holdings, Inc.'s assets below their book value (0.68 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Vyome Holdings, Inc.'s assets decreased by 55.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Vyome Holdings, Inc. (2003–2024)

The table below shows the annual total assets of Vyome Holdings, Inc. from 2003 to 2024.

Year Total Assets Change
2024-12-31 $4.79 Million -55.32%
2023-12-31 $10.73 Million -4.78%
2022-12-31 $11.27 Million -78.56%
2021-12-31 $52.53 Million +32.27%
2020-12-31 $39.71 Million +0.15%
2019-12-31 $39.66 Million -14.30%
2018-12-31 $46.27 Million -47.84%
2017-12-31 $88.70 Million +1159.84%
2016-12-31 $7.04 Million -39.23%
2015-12-31 $11.59 Million -19.46%
2014-12-31 $14.39 Million -45.48%
2013-12-31 $26.39 Million +1.12%
2012-12-31 $26.10 Million -19.67%
2011-12-31 $32.49 Million -16.03%
2010-12-31 $38.69 Million +138.60%
2009-12-31 $16.21 Million -42.66%
2008-12-31 $28.28 Million -52.11%
2007-12-31 $59.05 Million +63.74%
2006-12-31 $36.06 Million +211.95%
2005-12-31 $11.56 Million +1512.39%
2003-12-31 $717.00K --